Author details

Full Name

Michelle Monje

Affiliation

ORCID

Career Start Year

2000

Papers

134

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36917953	Cancer hallmarks intersect with neuroscience in the tumor microenvironment.		2023
37609137	Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability.	bioRxiv	2023
37748514	Distinguishing features of long COVID identified through immune profiling.	Nature	2023
37914930	Glioma synapses recruit mechanisms of adaptive plasticity.	Nature	2023
37652004	Tumors on different wavelengths.		2023
37637064	A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma.	Front Oncol	2023
37857838	Neuron-oligodendroglial interactions in health and malignant disease.		2023
36592076	Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma.	J Neuropathol Exp Neurol	2023
37343523	Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas.	Cell Rep Med	2023
37024595	Tumor inflammation-associated neurotoxicity.	Nat Med	2023
36711554	Neuronal-Activity Dependent Mechanisms of Small Cell Lung Cancer Progression.	bioRxiv	2023
37138086	Glioblastoma remodelling of human neural circuits decreases survival.	Nature	2023
37316719	The neuroscience of cancer.		2023
37122464	Kinase-Modulated Bioluminescent Indicators Enable Noninvasive Imaging of Drug Activity in the Brain.		2023
37001527	Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities.	Cancer Cell	2023
37380778	Remote neuronal activity drives glioma progression through SEMA4F.	Nature	2023
37059069	Cancer neuroscience: State of the field, emerging directions.	Cell	2023
36993539	Remote neuronal activity drives glioma infiltration via Sema4f.	bioRxiv	2023
37526549	Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).	Neuro Oncol	2023
37541803	CAR T cell therapies for diffuse midline glioma.		2023
35130560	GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.	Nature	2022
36376595	Adaptive and maladaptive myelination in health and disease.	Nature Reviews Neurology	2022
35589737	Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.	Nature Communications	2022
36305736	BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma.	Cancer Discov	2022
35768006	Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.	Cell	2022
35584667	H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscape.	Cell Reports	2022
35957525	Neuron-Glial Interactions in Health and Brain Cancer.	Advanced Biology	2022
36288726	The neurobiology of long COVID.	Neuron	2022
35817829	Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.	Nat Cancer	2022
35501379	Maladaptive myelination promotes generalized epilepsy progression.	Nature Neuroscience	2022
35931016	Invasive glioma cells: The malignant pioneers that follow the current.	Cell	2022
36327895	Microglia states and nomenclature: A field at its crossroads.	Neuron	2022
36055447	Mini-review: Aplastic myelin following chemotherapy.	Neuroscience Letters	2022
36471067	The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location.	Nat Genet	2022
35043113	Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain.	bioRxiv	2022
35311648	A light-gated transcriptional recorder for detecting cell-cell contacts.	Elife	2022
35259916	Neural Signaling in Cancer.	Annual Review of Neuroscience	2022
35027753	Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.	Nat Med	2022
33293232	The bright and the dark side of myelin plasticity: Neuron-glial interactions in health and disease.	Seminars in Cell and Developmental Biology	2021
34215733	Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma.	Nat Commun	2021
33674135	Microglia in Cancer Therapy-Related Cognitive Impairment.	Trends in Neurosciences	2021
34040258	NF1 mutation drives neuronalÂ activity-dependent initiation of optic glioma.	Nature	2021
34196691	Unravelling the Mechanisms of Cancer-Related Cognitive Dysfunction in Non-Central Nervous System Cancer.	JAMA Oncology	2021
34192527	Microenvironmental interactions of oligodendroglial cells.	Developmental Cell	2021
33977272	MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international study.	Neurooncol Adv	2021
33497554	Spinal Cord Injury - Healing from Within.	New England Journal of Medicine	2021
32882013	TERT and DNMT1 expression predict sensitivity to decitabine in gliomas.	Neuro Oncol	2021
33273172	Pediatric Brain Tumors.	Continuum (Minneap Minn)	2020
32302564	Roadmap for the Emerging Field of Cancer Neuroscience.	Cell	2020
32166329	Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma.	Neuro Oncol	2020